Adenomatoid odontogenic tumour - an unusual extrafollicular variant of the posterior mandible.

Adenomatoid odontogenic tumor (AOT) is a relatively uncommon distinct odontogenic neoplasm. Although this lesion was formerly considered to be the variant of ameloblastoma, its clinical features and biologic behavior indicate, that it is a separate entity. It is a tumor of odontogenic epithelium with duct like structures and with varying degrees of inductive change in the stroma. It is a benign and slow growing tumor which is usually located in the anterior region of the maxilla without pain, and represents 3% of all odontogenic tumors. Most adenomatoid odontogenic tumors (AOTs) occur intra-osseously. They surround the crowns and are attached to the necks of unerrupted teeth in a true follicular relationship, whereas the extrafollicular type has no relation with an impacted tooth, and the peripheral variant is attached to the gingival structures. The aim of this paper is to present a rare case of an extrafollicular AOT occurring in the posterior aspect of the mandible which is distinct

Proliferative verrucous leukoplakia and verrucous carcinoma - A diagnostic dilemma - Case Report.

The definition of leukoplakia is unusual in that it makes the diagnosis dependent not so much on definable appearances as on the exclusion of other entities that appear as oral white plaques. Leukoplakia or tobacco pouch keratosis may be seen on adjacent mucosal surfaces, and verrucous carcinoma is a lesion that may develop from the high risk precancer, proliferative verrucous leukoplakia (PVL). Verrucous carcinoma represents 1 % to 10% of all oral squamous cell carcinomas, depending on the local popularity of spit tobacco use. Many verrucous carcinomas arise from the oral mucosa in people who chronically use chewing tobacco or snuff, typically in the area where the tobacco is habitually placed. Both PVL and verrucous carcinoma may have been reported in the past by the name Oral florid papillomatosis.

Evaluation of clinical efficacy fluconazole mouthrinse for treatment of oral candidiasis.

Background: Oral Candidiasis is associated with multiple local and systemic factors. Morbidity and death in high risk patients may be prevented by recognition and adequate management.Flluconazole in a systemic antifungal medication that demonstrate clinical advantage in rinsing before swallowing. The purpose of present study was to evaluate the clinical efficacy of fluconazole aqueous mouth rinses to treat oral candidiasis.AIM: To evaluate the clinical efficacy of fluconazole mouth rinse for treatment of oral candiadiasis. Objectives: 1) To verify the mycological cure achieved by the drug supported clinical and candida culture.2) To determine the side effects associated with drug. Material and Methods - This study group consists of 30 patients who were clinically diagnosed as oral candidiasis and the subjects used 5 ml fluconazole ( 2mg/ml ) mouth rinse 3 times per day rinsing a minimum of 2 minutes and spitting it. The clinical out come and possible adverse effect were assessed after two weeks of treatment.Results: Follow –up done for the 30 patients. Complete systematic and clinical relief was noted in 86.66% and mycological cure in 73.3% of the patients. No side effects were reported. Conclusion: The use of fluconazole mouth rinses appears to be well tolerated and it is helpful in the treatment of oral Candidiasis effectively.